Altrafin AG’s Marvell Technology MRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,500
Closed -$1.89M 48
2025
Q3
$1.89M Hold
22,500
0.6% 29
2025
Q2
$1.74M Buy
+22,500
New +$1.4M 0.59% 29
2024
Q4
Sell
-21,500
Closed -$1.55M 51
2024
Q3
$1.55M Buy
21,500
+600
+3% +$41.4K 0.56% 35
2024
Q2
$1.46M Sell
20,900
-8,400
-29% -$589K 0.54% 38
2024
Q1
$2.08M Buy
29,300
+1,100
+4% +$75.3K 0.75% 36
2023
Q4
$1.7M Buy
28,200
+8,600
+44% +$464K 0.66% 40
2023
Q3
$1.06M Sell
19,600
-2,300
-11% -$136K 0.46% 44
2023
Q2
$1.31M Sell
21,900
-3,200
-13% -$155K 0.59% 41
2023
Q1
$1.09M Buy
25,100
+3,530
+16% +$149K 0.53% 43
2022
Q4
$799K Hold
21,570
0.47% 47
2022
Q3
$926K Buy
21,570
+380
+2% +$18.8K 0.55% 42
2022
Q2
$922K Buy
21,190
+1,150
+6% +$65.2K 0.5% 47
2022
Q1
$1.44M Buy
20,040
+11,776
+142% +$848K 0.56% 42
2021
Q4
$723K Buy
+8,264
New +$617K 0.26% 71

Other funds holding MRVL

Altrafin AG's MRVL Position: Q4 2025 in Review

Altrafin AG sold out of Marvell Technology (MRVL) in Q4 2025, closing a stake of 22,500 shares — an estimated $1.89M sold.

Altrafin AG first reported a position in MRVL in Q4 2021 and held it in 14 quarters. The position peaked at $2.08M in Q1 2024. 1,444 funds tracked by Wall St. Rank hold MRVL as of Q4 2025.

  • Altrafin AG reported no remaining Marvell Technology position as of Q4 2025 after selling out during the quarter.
  • Altrafin AG sold 22,500 Marvell Technology shares in Q4 2025, an estimated $1.89M.
  • Altrafin AG first reported a position in Marvell Technology in Q4 2021 and held it in 14 quarters.
  • Altrafin AG's Marvell Technology position peaked at $2.08M in Q1 2024.
  • 1,444 funds tracked by Wall St. Rank held Marvell Technology as of Q4 2025.

Based on Altrafin AG's 13F filing for Q4 2025, filed 13 Feb 2026.